Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (Q34507164)

2 August 2017

0 references

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (English)

1 reference

2 August 2017

0 references

cardiovascular disease

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Thomas Callender

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jonathan Emberson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

John Chalmers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Anthony Rodgers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Kazem Rahimi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Dena Ettehad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Connor A Emdin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Amit Kiran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

23 December 2015

1 reference

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

10022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

957-967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26724178%20AND%20SRC:MED&resulttype=core&format=json

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure and cardiovascular disease in the Asia Pacific region

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Treatment of hypertension in patients 80 years of age or older

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Telmisartan to prevent recurrent stroke and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Chinese Trial on Isolated Systolic Hypertension in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Practitioner's trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-hypertension II study) in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Association of Cardiometabolic Multimorbidity With Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of Blood Pressure Reduction in Mild Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure management in the 21st century: maximizing gains and minimizing waste

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021

High prevalence of chronic kidney disease in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2901225-8

7 January 2021